Case Report: Raloxifene in Postmenopausal Women with Psychosis: Preliminary Findings [4]

American Journal of Geriatric Psychiatry

Volumn 11, Issue 6, 2003, Pages 697-698

  Wong, Jiahui ^a   Seeman, Mary V ^b   Shapiro, Heather ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b Department of Psychiatry ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN; PLACEBO; RALOXIFENE;

ADULT; BREAST CANCER; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; LEARNING; LETTER; MEMORY; NEUROPSYCHOLOGICAL TEST; POSTMENOPAUSE; PSYCHOLOGICAL ASPECT; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RECALL; SCHIZOPHRENIA; SCORING SYSTEM; SHORT TERM MEMORY; TREATMENT OUTCOME;

EID: 0242575237     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajgp.11.6.697     Document Type: Letter

References (6)

1. Hoff AL, Kremen WS, Wieneke MH, et al: Association of estrogen levels with neuropsychological performance in women with schizophrenia. Am J Psychiatry 2001; 158:1134-1139
2. Nelson HD, Humphrey LL, Nygren P, et al: Postmenopausal hormone replacement therapy: scientific review. JAMA 2002; 288:872-881
3. Yaffe K, Krueger K, Somnath S, et al: Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 2001; 344:1207-1213
4. Kay SR, Fiszbein A, and Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261-176
5. Delis DC, Kramer JH, Kaplan E, et al: California Verbal Learning Test: Adult Version. San Antonio, TX. The Psychological Corporation 1987
6. Norman MA, Evans JD, Miller W, et al: Demographically corrected norms for the California Verbal Learning Test. J Clin Exp Neuropsychol 2000; 22:80-94